FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2179796747> ?p ?o ?g. }

• W2179796747 endingPage "24" @default.
• W2179796747 startingPage "14" @default.
• W2179796747 abstract "Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for patients with malignant peritoneal mesothelioma has resulted in improved disease control and increased survival. Despite these results, there are significant perioperative risks associated with this aggressive procedure that necessitate consideration of prognostic markers during patient selection. The molecular pathogenesis of peritoneal mesothelioma remains relatively unknown, but extrapolation of findings from their pleural counterpart would suggest frequent alterations in CDKN2A, NF2, and BAP1. Homozygous deletions in CDKN2A portend a worse overall survival in peritoneal mesothelioma. However, the prevalence and prognostic significance of NF2 and BAP1 abnormalities has not been studied. Dual-color fluorescence in situ hybridization using CDKN2A and NF2 locus-specific probes and BAP1 immunohistochemistry identified homozygous CDKN2A deletions (n=25, 29%), hemizygous NF2 loss (n=30, 35%), and/or loss of BAP1 protein expression (n=49, 57%) in 68 of 86 (79%) peritoneal mesotheliomas. Homozygous CDKN2A deletions or hemizygous NF2 loss correlated with shorter progression-free survival (P<0.02) and poor overall survival (P<0.03). Moreover, the significance of these findings was cumulative. Patients harboring both homozygous CDKN2A deletions and hemizygous NF2 loss had a 2-year progression-free survival rate of 9% with a median of 6 months (P<0.01) and overall survival rate of 18% with a median of 8 months (P<0.01). By multivariate analysis, combined homozygous CDKN2A deletions and hemizygous NF2 loss was a negative prognostic factor for both progression-free survival and overall survival, independent of patient age, peritoneal cancer index, completeness of cytoreduction, and extent of invasion. In contrast, loss of BAP1 was not associated with clinical outcome. In summary, homozygous deletions in CDKN2A and hemizygous loss of NF2 as detected by fluorescence in situ hybridization would confer a poor clinical outcome and may guide future treatment decisions for patients with peritoneal mesothelioma." @default.
• W2179796747 created "2016-06-24" @default.
• W2179796747 creator A5023598971 @default.
• W2179796747 creator A5027656337 @default.
• W2179796747 creator A5030798278 @default.
• W2179796747 creator A5050352682 @default.
• W2179796747 creator A5051030840 @default.
• W2179796747 creator A5051902236 @default.
• W2179796747 creator A5054409783 @default.
• W2179796747 creator A5056955251 @default.
• W2179796747 creator A5073785005 @default.
• W2179796747 creator A5073859061 @default.
• W2179796747 creator A5089205330 @default.
• W2179796747 date "2016-01-01" @default.
• W2179796747 modified "2023-10-16" @default.
• W2179796747 title "The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma" @default.
• W2179796747 cites W102573316 @default.
• W2179796747 cites W148347120 @default.
• W2179796747 cites W17791541 @default.
• W2179796747 cites W1975481321 @default.
• W2179796747 cites W1980807804 @default.
• W2179796747 cites W1982067611 @default.
• W2179796747 cites W1988500296 @default.
• W2179796747 cites W1989762654 @default.
• W2179796747 cites W1998543226 @default.
• W2179796747 cites W2003892998 @default.
• W2179796747 cites W2006752813 @default.
• W2179796747 cites W2007265317 @default.
• W2179796747 cites W2011730160 @default.
• W2179796747 cites W2014786655 @default.
• W2179796747 cites W2033444110 @default.
• W2179796747 cites W2035998397 @default.
• W2179796747 cites W2042328755 @default.
• W2179796747 cites W2045712356 @default.
• W2179796747 cites W2047943094 @default.
• W2179796747 cites W2048474610 @default.
• W2179796747 cites W2070195376 @default.
• W2179796747 cites W2074498240 @default.
• W2179796747 cites W2078614449 @default.
• W2179796747 cites W2095824051 @default.
• W2179796747 cites W2095826251 @default.
• W2179796747 cites W2101798074 @default.
• W2179796747 cites W2111991867 @default.
• W2179796747 cites W2113588085 @default.
• W2179796747 cites W2118211985 @default.
• W2179796747 cites W2122170961 @default.
• W2179796747 cites W2125173333 @default.
• W2179796747 cites W2125600615 @default.
• W2179796747 cites W2128656163 @default.
• W2179796747 cites W2131934427 @default.
• W2179796747 cites W2141155075 @default.
• W2179796747 cites W2150737595 @default.
• W2179796747 cites W2157337438 @default.
• W2179796747 cites W2158757628 @default.
• W2179796747 cites W2164878282 @default.
• W2179796747 cites W2165354014 @default.
• W2179796747 cites W2166116307 @default.
• W2179796747 cites W2168598108 @default.
• W2179796747 cites W2329699996 @default.
• W2179796747 cites W2405615959 @default.
• W2179796747 cites W2416119553 @default.
• W2179796747 cites W3190980536 @default.
• W2179796747 doi "https://doi.org/10.1038/modpathol.2015.121" @default.
• W2179796747 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26493618" @default.
• W2179796747 hasPublicationYear "2016" @default.
• W2179796747 type Work @default.
• W2179796747 sameAs 2179796747 @default.
• W2179796747 citedByCount "109" @default.
• W2179796747 countsByYear W21797967472016 @default.
• W2179796747 countsByYear W21797967472017 @default.
• W2179796747 countsByYear W21797967472018 @default.
• W2179796747 countsByYear W21797967472019 @default.
• W2179796747 countsByYear W21797967472020 @default.
• W2179796747 countsByYear W21797967472021 @default.
• W2179796747 countsByYear W21797967472022 @default.
• W2179796747 countsByYear W21797967472023 @default.
• W2179796747 crossrefType "journal-article" @default.
• W2179796747 hasAuthorship W2179796747A5023598971 @default.
• W2179796747 hasAuthorship W2179796747A5027656337 @default.
• W2179796747 hasAuthorship W2179796747A5030798278 @default.
• W2179796747 hasAuthorship W2179796747A5050352682 @default.
• W2179796747 hasAuthorship W2179796747A5051030840 @default.
• W2179796747 hasAuthorship W2179796747A5051902236 @default.
• W2179796747 hasAuthorship W2179796747A5054409783 @default.
• W2179796747 hasAuthorship W2179796747A5056955251 @default.
• W2179796747 hasAuthorship W2179796747A5073785005 @default.
• W2179796747 hasAuthorship W2179796747A5073859061 @default.
• W2179796747 hasAuthorship W2179796747A5089205330 @default.
• W2179796747 hasBestOaLocation W21797967471 @default.
• W2179796747 hasConcept C10515644 @default.
• W2179796747 hasConcept C121608353 @default.
• W2179796747 hasConcept C126322002 @default.
• W2179796747 hasConcept C142724271 @default.
• W2179796747 hasConcept C143998085 @default.
• W2179796747 hasConcept C2777407522 @default.
• W2179796747 hasConcept C2778995398 @default.
• W2179796747 hasConcept C2780265364 @default.
• W2179796747 hasConcept C37846818 @default.

• next